The Journal of Nuclear Medicine (JNM) has demonstrated outstanding performance in the 2025 Journal Citation Reports released by Clarivate, affirming its position as a premier publication in the domain of medical imaging. With an impact factor that climbed from 9.1 to an impressive 9.6, JNM now ranks eighth among 217 medical imaging journals globally. This elevation not only marks quantitative growth but also signals the journal’s deepening influence on the scientific community engaged in nuclear medicine and molecular imaging.
JNM’s ascendancy occurs during a period marked by rapid technological and research advances in nuclear medicine and molecular imaging. These fields are crucial for innovative diagnostics and therapeutics, often involving the use of radiotracers and molecular probes that provide functional and metabolic information beyond traditional anatomical imaging. The journal’s success mirrors its ability to capture and disseminate cutting-edge research pivotal to the evolution of these techniques, ensuring that practitioners and researchers have timely access to transformative knowledge.
The journal’s impact factor is a reflection of the average number of citations received per paper published over a two-year period. The increase from 9.1 to 9.6 represents heightened scholarly influence, indicative of the relevance and quality of the research JNM publishes. Beyond the impact factor, the total citation count grew by nearly 10 percent, rising to 32,569 citations in 2025 from 29,698 in the previous year. Such a metric underscores the journal’s role as a critical resource in advancing nuclear medicine research.
An important metric reflecting how quickly articles are recognized within their field, the immediacy index, also increased for JNM—from 2.6 in 2024 to 2.8 in 2025. This signifies that new research published in the journal is promptly cited by peers, emphasizing the currency and applicability of JNM’s publications in ongoing scientific dialogue. Rapid citation often correlates with the journal’s ability to identify and prioritize topics of emerging importance to the field.
Other bibliometric indicators further validate JNM’s stature. The journal citation index, which normalizes citation data over three years, alongside the Eigenfactor score, a measure of the journal’s overall importance to science based on network theory, both attest to JNM’s growing scientific relevance. Additionally, the article influence score, which gauges the average influence of each article over the first five years post-publication, remains strong, showcasing the enduring value of JNM’s content.
The continued success of JNM is attributed to a dedicated editorial team and robust peer-review process, creating an environment that nurtures high-quality scientific communication. Under the leadership of Johannes Czernin, MD, the editor-in-chief and a professor at UCLA’s David Geffen School of Medicine, the journal has adeptly aligned its editorial policies and thematic focus to reflect the latest developments and challenges in molecular imaging and theranostics.
Theranostics, an emerging cornerstone of precision medicine combining targeted diagnostics and therapeutics, is swiftly transforming patient care paradigms. JNM plays a key role in disseminating pivotal studies in this area, enabling the scientific community to interpret, validate, and implement novel theranostic strategies. The journal’s influence therefore extends beyond publication, fostering a scientific ecosystem that supports translational research and clinical application.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), which publishes JNM, supports this mission by fostering scientific exchange and promoting the integration of molecular imaging insights into clinical practice. The society’s global reach and commitment to advancing education and research in nuclear medicine underpin the journal’s prominent position and ensure its content remains relevant to practitioners worldwide.
JNM’s digital presence, accessed more than 15 million times annually, reflects its importance as a knowledge repository. The journal leverages contemporary dissemination channels, including social media platforms like Twitter, Facebook, and LinkedIn, to enhance visibility, engage with a diverse audience, and catalyze collaborative discussions on emerging nuclear medicine topics.
The metrics reported in Clarivate’s Journal Citation Reports are a testament to the vibrant scholarly activity surrounding molecular imaging and underline JNM’s central role in this intellectual landscape. The journal not only captures high-impact research but also contributes to shaping the direction of future investigations by spotlighting innovative methodologies and clinical advancements.
In a shifting academic landscape, where rapid information exchange and evidence-based innovation are paramount, JNM stands as a beacon of rigorous scientific inquiry. Its increasing impact factor and citation metrics highlight not only its prestige but also its responsibility—serving as a trusted platform for research that drives the cutting edge of nuclear medicine and molecular imaging globally.
For continuous updates on groundbreaking research and editorial insights, the scientific community is encouraged to visit the Journal of Nuclear Medicine website and engage with its content through various social media channels maintained by the journal. This ongoing engagement supports the creation of a dynamic and informed community committed to enhancing patient outcomes through advanced imaging and theranostics.
Subject of Research: Nuclear Medicine, Molecular Imaging, Theranostics
Article Title: The Journal of Nuclear Medicine’s Expanding Influence in Medical Imaging: Insights from the 2025 Journal Citation Reports
News Publication Date: June 30, 2026
Web References:
JNM Website: https://jnm.snmjournals.org/
JNM Twitter: https://twitter.com/JournalofNucMed
JNM Facebook: https://www.facebook.com/JournalofNucMed
JNM LinkedIn: http://www.linkedin.com/company/journal-nuc-med
SNMMI Website: http://www.snmmi.org/
Image Credits: Courtesy of SNMMI
Keywords: Nuclear medicine, Molecular imaging, Theranostics, Medical imaging, Journal impact factor, Clarivate Journal Citation Reports, Precision medicine
Tags: Clarivate Journal Citation Reports 2025cutting-edge nuclear medicine researchJournal of Nuclear Medicine impact factor 2025medical imaging journal rankingsmedical imaging publication performancemolecular imaging diagnosticsmolecular probes in medical imagingnuclear medicine research advancesnuclear medicine scientific influenceradiotracer technology in nuclear medicinescholarly impact in nuclear medicinetransformative molecular imaging techniques
